ANI closes $75M public offering of common stock

ANI announced the closing of its previously announced underwritten public offering. A total of 1,500,000 shares of its common stock were sold at a public offering price of $50 per share.

The gross proceeds of the offering to the company are $75 million, before deducting the underwriting discounts and commissions and offering expenses.

[Read more: ANI inks $163.5M deal to acquire Novitium Pharma] 

In addition, ANI granted the underwriters a 30-day option to purchase up to an additional 225,000 shares of common stock at the public offering price, less underwriting discounts and commissions.

Guggenheim Securities acted as lead book-running manager for the offering. Raymond James also acted as book-running manager for the offering. H.C. Wainwright acted as lead manager for the offering.

[Read more: FDA gives ANI green light for Cortrophin Gel]